Ramy Riad: Advancing Plasma-Derived Therapies Through Partnership
Ramy Riad, President of Plasma-Derived Therapies Business Unit at Takeda, shared a post on LinkedIn:
“Wrapping up a productive first day at IPPC 2026, hosted by Plasma Protein Therapeutics Association (PPTA), with a real sense of momentum.
This year’s theme — ‘Resilience, Reach and Responsibility’ — perfectly captures the leadership imperative facing our industry.
No single organization can sustain the plasma ecosystem alone.
It requires long‑term partnerships and shared responsibility across the value chain.
Today’s conversations reinforced how essential collaboration is to protect access for the patients who depend on plasma-derived therapies.
Looking forward to the sessions ahead and to connecting with fellow leaders shaping the future of plasma.”
Stay updated with Hemostasis Today.
-
May 16, 2026, 16:50Amanda Lund on Lymphatic Vessels as Body’s Defense in Cancer – NYU Langone Health
-
May 16, 2026, 16:36Deep Vein Thrombosis Month with Mark Goldin and Timothy Wu – Northwell Health
-
May 16, 2026, 16:27Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
-
May 16, 2026, 16:26Tagreed Alkaltham: Why Can Some Apheresis Donors Donate More Frequently?
-
May 16, 2026, 16:26Living with Hemophilia Looks Very Different Today Than It Did Decades Ago – UNC Health
-
May 16, 2026, 16:23Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference – RFHMO
-
May 16, 2026, 16:22Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
-
May 16, 2026, 16:20Abdallah Othman: Exploring the Detailed Diagram of the Coronary Arteries
-
May 16, 2026, 16:16The Minute That Saved a Life – Elle’s Battle with a Dismissed Blood Clot – National Blood Clot Alliance